Effect of Bardoxolone Methyl on the Urine Albumin-To-Creatinine Ratio in Patients With Type 2 Diabetes and Stage 4 Chronic Kidney Disease.

Kidney International - United States
doi 10.1016/j.kint.2019.04.027
Full Text
Abstract

Available in full text

Categories
Nephrology
Date
Authors
Publisher

Elsevier BV

Related search

Detection of Chronic Kidney Disease With Creatinine, Cystatin C, and Urine Albumin-To-Creatinine Ratio and Association With Progression to End-Stage Renal Disease and Mortality

JAMA - Journal of the American Medical Association
Medicine
2011English

The Longitudinal Effect of Subclinical Hypothyroidism on Urine Microalbumin-To-Urine Creatinine Ratio in Patients With Type 2 Diabetes Mellitus

BMC Endocrine Disorders
MedicineEndocrinologyMetabolismDiabetes
2019English

Cardiac and Renal Function in Patients With Type 2 Diabetes Who Have Chronic Kidney Disease: Potential Effects of Bardoxolone Methyl

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2012English

Bardoxolone Methyl and Kidney Function in CKD With Type 2 Diabetes

New England Journal of Medicine
Medicine
2011English

Correlation Between Albumin Creatinine Ratio and Hypertension in Type 2 Diabetes

JHeS (Journal of Health Studies)
2020English

Effect of Alogliptin on Hypertensive Chronic Kidney Disease Patients With Type 2 Diabetes Mellitus

Australasian Medical Journal
Medicine
2018English

Inсretin-Based Therapy in Patients With Type 2 Diabetes and Chronic Kidney Disease

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

Reno-Protective Effect of Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Blockers in Type 2 Diabetic Nephropathy With Elevated Urine Albumin to Creatinine Ratio

International Journal of Advances in Medicine
2019English

Cystatin C Study in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease

Medical News of North Caucasus
Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy